Intravenous adenosine triphosphate during wide QRS complex tachycardia: Safety, therapeutic efficacy, and diagnostic utility
- 1 April 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 88 (4) , 337-343
- https://doi.org/10.1016/0002-9343(90)90486-w
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- “Nodoventricular” accessory pathway: Evidence for a distinct accessory atrioventricular pathway with atrioventricular node-like propertiesJournal of the American College of Cardiology, 1988
- Comparative quantitative electrophysiologic effects of adenosine triphosphate on the sinus node and atrioventricular nodeThe American Journal of Cardiology, 1988
- Hazards of intravenous verapamil for sustained ventricular tachycardiaThe American Journal of Cardiology, 1987
- Wide Complex Tachycardia: Misdiagnosis and Outcome After Emergent TherapyAnnals of Internal Medicine, 1986
- MISDIAGNOSIS OF CHRONIC RECURRENT VENTRICULAR TACHYCARDIAThe Lancet, 1985
- Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway.Circulation, 1985
- Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.Circulation, 1983
- Electrophysiologic effects of adenosine-5'-triphosphate on atrioventricular reentrant tachycardia.Circulation, 1983
- Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.Circulation, 1982
- Intravenous Verapamil for Termination of Re-Entrant Supraventricular TachycardiasAnnals of Internal Medicine, 1980